Back to Search Start Over

TIRC7 inhibits T cell proliferation by modulation of CTLA-4 expression.

Authors :
Bulwin GC
Heinemann T
Bugge V
Winter M
Lohan A
Schlawinsky M
Schulze A
Wälter S
Sabat R
Schülein R
Wiesner B
Veh RW
Löhler J
Blumberg RS
Volk HD
Utku N
Source :
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2006 Nov 15; Vol. 177 (10), pp. 6833-41.
Publication Year :
2006

Abstract

Ab targeting of TIRC7 has been shown previously to inhibit T cell proliferation and Th1 lymphocyte-associated cytokine production. In this study, we demonstrate that Ab targeting of TIRC7 induces early cell surface expression of CTLA-4. The majority of stimulated CD4+ and CD8+ human T cells coexpress CTLA-4 and TIRC7. Similar to CTLA-4, TIRC7 rapidly accumulates at the site of Ag adhesion upon T cell activation. TIRC7 seems to colocalize with CTLA-4 in human T cells, and both molecules are associated with clathrin-coated vesicles, indicating they share intracellular transport systems. Moreover, Ab targeting of TIRC7 results in an early activation of CTLA-4 transcription. The inhibition of cell proliferation mediated by TIRC7 is dependent on CTLA-4 expression because the TIRC7-mediated inhibitory effects on cell proliferation and cytokine expression are abolished by Ab blockade of CTLA-4. Splenocytes obtained from CTLA-4-deficient mice are not responsive to TIRC7 Ab targeting. Thus, TIRC7 acts as an upstream regulatory molecule of CTLA-4 expression.

Details

Language :
English
ISSN :
0022-1767
Volume :
177
Issue :
10
Database :
MEDLINE
Journal :
Journal of immunology (Baltimore, Md. : 1950)
Publication Type :
Academic Journal
Accession number :
17082597
Full Text :
https://doi.org/10.4049/jimmunol.177.10.6833